NewAmsterdam Pharma Co N.V (NAMS) Other Gross PP&E Adjustments: 2022-2025
Historic Other Gross PP&E Adjustments for NewAmsterdam Pharma Co N.V (NAMS) over the last 2 years, with Sep 2025 value amounting to -$2.3 million.
- NewAmsterdam Pharma Co N.V's Other Gross PP&E Adjustments rose 23.00% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.2 million, marking a year-over-year decrease of 37.59%. This contributed to the annual value of -$3.2 million for FY2024, which is 52.97% down from last year.
- As of Q3 2025, NewAmsterdam Pharma Co N.V's Other Gross PP&E Adjustments stood at -$2.3 million, which was up 22.54% from -$3.0 million recorded in Q2 2025.
- NewAmsterdam Pharma Co N.V's 5-year Other Gross PP&E Adjustments high stood at -$1.7 million for Q1 2024, and its period low was -$3.6 million during Q1 2025.
- Moreover, its 3-year median value for Other Gross PP&E Adjustments was -$2.7 million (2025), whereas its average is -$2.6 million.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first spiked by 31.53% in 2023, then plummeted by 111.68% in 2025.
- Over the past 4 years, NewAmsterdam Pharma Co N.V's Other Gross PP&E Adjustments (Quarterly) stood at -$3.1 million in 2022, then surged by 31.53% to -$2.1 million in 2023, then tumbled by 52.97% to -$3.2 million in 2024, then rose by 23.00% to -$2.3 million in 2025.
- Its Other Gross PP&E Adjustments was -$2.3 million in Q3 2025, compared to -$3.0 million in Q2 2025 and -$3.6 million in Q1 2025.